Skip to main content

Michael Wood

Head of Investor Relations

Milestone Pharmaceuticals Inc. (MIST)

Equibles does not estimate personal net worth.

Get an email with a short summary when Milestone Pharmaceuticals Inc. publishes a filing, an earnings call transcript or a press release.

Get MIST alerts

About Michael Wood

Michael Wood is recorded as Head of Investor Relations at Milestone Pharmaceuticals Inc. (MIST). Michael Wood has spoken on 4 earnings calls across 1 company, most recently for Milestone Pharmaceuticals Inc. on November 13, 2026. Milestone Pharmaceuticals Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Milestone Pharmaceuticals Inc. includes Joseph Oliveto (CEO and Board Member), Amit Hasija (CFO), Jeffrey Nelson (COO) and 7 others.

Michael Wood on recent calls

“Thank you and good morning, everyone, and welcome to Milestone Pharmaceuticals' third quarter 2026 financial results and business update conference call.”
Head of Investor Relations, Third Quarter 2026 Financial Results ·
“Thank you and good morning everyone and welcome to Milestone Pharmaceuticals second quarter 2026 financial results and business update conference call.”
Head of Investor Relations, Milestone Pharmaceuticals Inc. Q2 FY2026 Earnings Call ·
“Good morning, everyone, and welcome to the Milestone Pharmaceuticals first quarter 2026 financial results and business update conference call. Earlier this morning, the company issued a press release providing an overview of its financial results for the quarter ended March 31, 2026, and recent corporate highlights.”
Head of Investor Relations, Milestone Pharmaceuticals Inc. Q1 FY2026 Earnings Call ·
“Good morning, everyone. and a welcome to the Milestone Pharmaceuticals' full year 2025 financial results and business update conference call. Earlier this morning, the company issued a press release providing an overview of its financial results for the year ended December 31, 2025, and recent corporate highlights.”
Head of Investor Relations, Earnings conference call (announced in 8-K) ·

Affiliation history

Company network

Leadership on record at Milestone Pharmaceuticals Inc.

Recent activity